Antibodies to CD200R
US8212008B2 · kind B2 · utility
7Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2007 |
| Grant date | Jul 3, 2012 |
| Priority date | — |
| Expiry date | Jan 8, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to binding compounds specific for the human inhibitory CD200R and uses thereof. More specifically, the invention relates to antibodies that recognize the human inhibitory CD200R and modulates its activity in inflammatory and autoimmune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.